I Correlati
IL-17 e drug survival: l'esperienza torinese
Predicting skin clearance at week 12 in real worLd: Risultati dello studio PsoHo
Efficacy of Ixekizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Prediabetes or Type 2 Diabetes
Why Obesity Matters: una malattia sistemica sottovalutata
